remdesivir | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
October 06, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, OCTOBER 06, 2025

remdesivir

remdesivir

antiviral drug Remdesivir. Photo : BSS/AFP

Gilead's remdesivir reduces Covid-19 mortality risk

The drugmaker said on Monday it analyzed data from 98,654 patients from three retrospective studies of the real-world treatment of hospitalised Covid-19 patients.

Photo: Collected

Man arrested in Ahmedabad with Remdesivir vials for sale in Bangladesh

Harsh Vardhan Shringla

India to receive medical support from more than 40 countries, including Bangladesh

Bangladesh to send Remdesivir to India next week

Bangladesh to send Remdesivir to India next week

Photo :Times of India

India approaches Bangladesh and other countries for Remdisivir

FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company is seen in Oceanside, California, US, April 29, 2020. REUTERS/Mike Blake/File Photo/File Photo

Gilead to help India boost remdesivir production, promises at least 450,000 vials

Photo: Collected

India seeks remdesivir, oxygen from EU, aid expected soon - EU official

Photo: Collected.

Remdesivir has side effects too, warns expert as demand rises in Covid 2nd wave

Photo: Collected

India clarifies on Remdesivir, says it is ‘not life-saving drug’

antiviral drug Remdesivir. Photo : BSS/AFP

Embattled Indian state looks to Bangladesh pharmas for supplies of Remdesivir

Photo: Collected

India bans exports of anti-viral drug Remdesivir as Covid-19 cases surge

Rejected by WHO, applauded by Bangladesh – why is remdesivir still being used?

Rejected by WHO, applauded by Bangladesh – why is remdesivir still being used?

Photo: Collected

EU drugs regulator studying expanded use of Covid-19 drug remdesivir

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net